Combined cd8+ and cd4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection

Haematologica

Volumn 95, Issue 11, 2010, Pages 1943-1951

  Zandvliet, Maarten L ^a   Falkenburg, J h Frederik ^a   van Liempt, Ellis ^a   Veltrop Duits, Louise A ^a   Lankester, Arjan C ^a   Kalpoe, Jayant S ^b   Kester, Michel G D ^a   van der Steen, Dirk M ^a   van Tol, Maarten J ^a   Willemze, Roel ^a   Guchelaar, Henk Jan ^a   Schilham, Marco W ^a   Meij, Pauline ^a  

^a Department of Clinical Pharmacy and Toxicology ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus infection; Adenovirus specific T cells; Adoptive immunotherapy; Allogeneic stem cell transplantation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADENOVIRUS INFECTION; ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; GRAFT RECIPIENT; HUMAN; HUMAN CELL; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIREMIA; VIRUS IMMUNITY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADOPTIVE TRANSFER; ADULT; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VIREMIA;

EID: 78149249171     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.022947     Document Type: Article

References (38)

1. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3(2):79-86.
2. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis. 2006; 43(3):331-9.
3. Lion T, Baumgartinger R, Watzinger F, Matthes-Martin S, Suda M, Preuner S, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102 (3):1114-20.
4. Kalpoe JS, van der Heiden PL, Barge RM, Houtzager S, Lankester AC, van Tol MJ, et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol. 2007;78(4):314-21.
5. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 2002;100(5):1619-27.
6. van Tol MJ, Claas EC, Heemskerk B, Veltrop-Duits LA, de Brouwer CS, van Vreeswijk T, et al. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. Bone Marrow Transplant. 2005;35 (Suppl 1):S73-S6.
7. Feuchtinger T, Lucke J, Hamprecht K, Richard C, Handgretinger R, Schumm M, et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2005;128(4):503-9.
8. Heemskerk B, Lankester AC, van Vreeswijk T, Beersma MF, Claas EC, Veltrop-Duits LA, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis. 2005;191(4):520-30.
9. Myers GD, Bollard CM, Wu MF, Weiss H, Rooney CM, Heslop HE, et al. Reconstitution of adenovirus-specific cellmediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39 (11):677-86.
10. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis. 1995;171(5):1090-6.
11. Smith CA, Woodruff LS, Kitchingman GR, Rooney CM. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J Virol. 1996;70(10): 6733-40.
12. Olive M, Eisenlohr LC, Flomenberg P. Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. Viral Immunol. 2001;14(4):403-13.
13. Hamel Y, Blake N, Gabrielsson S, Haigh T, Jooss K, Martinache C, et al. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. Hum Gene Ther. 2002;13 (7):855-66.
14. Onion D, Crompton LJ, Milligan DW, Moss PA, Lee SP, Mautner V. The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J Gen Virol. 2007;88(Pt 9):2417-25.
15. Tang J, Olive M, Pulmanausahakul R, Schnell M, Flomenberg N, Eisenlohr L, et al. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology. 2006;350(2):312-22.
16. Tang J, Olive M, Champagne K, Flomenberg N, Eisenlohr L, Hsu S, et al. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther. 2004;11(18):1408-15.
17. Veltrop-Duits LA, Heemskerk B, Sombroek CC, van Vreeswijk T, Gubbels S, Toes RE, et al. Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Eur J Immunol. 2006;36(9):2410-23.
18. Leen AM, Sili U, Vanin EF, Jewell AM, Xie W, Vignali D, et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup- specific CD8+ T cells. Blood. 2004; 104(8):2432-40.
19. Leen AM, Christin A, Khalil M, Weiss H, Gee AP, Brenner MK, et al. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol. 2008;82(1):546-54.
20. Feuchtinger T, Richard C, Joachim S, Scheible MH, Schumm M, Hamprecht K, et al. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. J Immunother. 2008;31(2):199-206.
21. Heemskerk B, van Vreeswijk T, Veltrop- Duits LA, Sombroek CC, Franken K, Verhoosel RM, et al. Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J Immunol. 2006;177(12):8851-9.
22. Chakrabarti S. Adenovirus infections after hematopoietic stem cell transplantation: still unravelling the story. Clin Infect Dis. 2007;45(8):966-8.
23. Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, et al. Safe adoptive transfer of virus-specific Tcell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134(1):64-76.
24. Chatziandreou I, Gilmour KC, McNicol AM, Costabile M, Sinclair J, Cubitt D, et al. Capture and generation of adenovirus specific T cells for adoptive immunotherapy. Br J Haematol. 2007;136(1):117-26.
25. Comoli P, Schilham MW, Basso S, van Vreeswijk T, Bernardo ME, Maccario R, et al. T-cell lines specific for peptides of adeno virus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors. J Immunother. 2008;31(6):529-36.
26. Leen AM, Sili U, Savoldo B, Jewell AM, Piedra PA, Brenner MK, et al. Fiber-modified adenoviruses generate subgroup crossreactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood. 2004;103(3):1011-9.
27. Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS, et al. Monoculturederived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12(10):1160-6.
28. Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens. J Immunother. 2007;30 (5):544-56.
29. Fujita Y, Leen AM, Sun J, Nakazawa Y, Yvon E, Heslop HE, et al. Exploiting cytokine secretion to rapidly produce multivirus- specific T cells for adoptive immunotherapy. J Immunother. 2008;31 (7):665-74.
30. Claas EC, Schilham MW, de Brouwer CS, Hubacek P, Echavarria M, Lankester AC, et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol. 2005;43(4):1738-44.
31. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274(5284):94-6.
32. Jedema I, van der Werff NM, Barge RM, Willemze R, Falkenburg JH. New CFSEbased assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood. 2004;103(7):2677-82.
33. Zandvliet ML, Falkenburg JH, Jedema I, Willemze R, Guchelaar HJ, Meij P. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy. J Immunother. 2009;32(5):513-23.
34. Faber LM, Luxemburg-Heijs SA, Willemze R, Falkenburg JH. Generation of leukemiareactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med. 1992;176(5):1283-9.
35. Meij P, Zandvliet ML, Van der Heiden PLJ, Jedema I, Van Egmond HM, Cox LMP, et al. Generation and administration of CMV pp65-specific donor T-cell lines for treatment of CMV reactivation after allogeneic stem cell transplantation. EBMT [Abstract] O-292 - 33rd Annual Meeting of the European Group for Blood and Marrow Transplantation, Lyon, France, 2007.
36. Mackinnon S, Thomson K, Verfuerth S, Peggs K, Lowdell M. Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells Mol Dis. 2008;40(1):63-7.
37. Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest. 2008;118(1):294-305.
38. Zandvliet ML, Liempt EV, Jedema I, Veltrop-Duits LA, Willemze R, Guchelaar HJ, et al. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Cytotherapy. 2010 Jan 18. [Epub ahead of print]